| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1 |
| 1 | DULAGLUTIDE | 1 |
| 2 | METFORMIN | 1 |
| 3 | METFORMIN ER 500 MG | 1 |
| 4 | METFORMIN ER 750 MG | 1 |
| 5 | SOFOSBUVIR | 1 |
| 6 | TAFAMIDIS MEGLUMINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAFAMIDIS MEGLUMINE | 1 | 0.0002 |
| 1 | SOFOSBUVIR | 1 | 0.0001 |
| 2 | DULAGLUTIDE | 1 | 0.0000 |
| 3 | METFORMIN ER 500 MG | 1 | 0.0000 |
| 4 | ADALIMUMAB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 1 |
| 1 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 1 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |